Sanofi to Shut British Plant

Products affected by generic competition

French pharmaceutical company Sanofi, an IW1000 company, on March 14 said that it planned to shut a drug-manufacturing plant in Britain that currently employs about 450 staff.

Plans to close the Fawdon Manufacturing Centre in Newcastle-upon-Tyne, northeastern England, by mid-2015 comes amid "an adverse economic climate and the challenging pharmaceutical market in Europe," Sanofi said.
"Under the proposal the plant, which makes solid dose oral medications mainly for UK and European markets, would be scheduled to close by mid-2015."

"The products manufactured at the Fawdon site have been adversely impacted by other factors, including generic competition, resulting in a fall in demand and production volumes."

Copyright Agence France-Presse, 2012

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish